Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronit Weizman

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Frontiers in Human Neuroscience|August 15, 2014
Does co-morbid obsessive-compulsive disorder modify the abnormal language processing in schizophrenia patients? An FMRI studyMaya Bleich-Cohen, Michael Poyurovsky, Talma Hendler, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 28, 2002
Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patientsYoram Barak, Eyal Shamir, Hanna Zemishlani, et al.
Psychiatry Research|March 23, 2012
Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorderSarit Faragian, Camil Fuchs, Artashes Pashinian, et al.
Journal of Clinical Psychopharmacology|June 27, 2003
Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot studyMichael Poyurovsky, Svetlana Epshtein, Camil Fuchs, et al.
Behavioural Brain Research|April 1, 2006
Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigmAnat Milman, Ronit Weizman, Tova Rigai, et al.
Psychopharmacology|December 15, 2012
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combinationMichael Poyurovsky, Camil Fuchs, Artashez Pashinian, et al.
Human Psychopharmacology|October 31, 2002
Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot studyPaz Toren, Sofia Eldar, Nathaniel Laor, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 7, 2009
The antinociceptive properties of reboxetine in acute painShaul Schreiber, Ruthi Frishtick, Ina Volis, et al.
Schizophrenia Research|November 26, 2011
Diminished language lateralization in schizophrenia corresponds to impaired inter-hemispheric functional connectivityMaya Bleich-Cohen, Haggai Sharon, Ronit Weizman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 26, 2003
Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled studyMichael Poyurovsky, Danny Koren, Inna Gonopolsky, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Frontiers in Human Neuroscience|August 15, 2014
Does co-morbid obsessive-compulsive disorder modify the abnormal language processing in schizophrenia patients? An FMRI studyMaya Bleich-Cohen, Michael Poyurovsky, Talma Hendler, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 28, 2002
Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patientsYoram Barak, Eyal Shamir, Hanna Zemishlani, et al.
Psychiatry Research|March 23, 2012
Age-of-onset of schizophrenic and obsessive-compulsive symptoms in patients with schizo-obsessive disorderSarit Faragian, Camil Fuchs, Artashes Pashinian, et al.
Journal of Clinical Psychopharmacology|June 27, 2003
Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot studyMichael Poyurovsky, Svetlana Epshtein, Camil Fuchs, et al.
Behavioural Brain Research|April 1, 2006
Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigmAnat Milman, Ronit Weizman, Tova Rigai, et al.
Psychopharmacology|December 15, 2012
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combinationMichael Poyurovsky, Camil Fuchs, Artashez Pashinian, et al.
Human Psychopharmacology|October 31, 2002
Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot studyPaz Toren, Sofia Eldar, Nathaniel Laor, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 7, 2009
The antinociceptive properties of reboxetine in acute painShaul Schreiber, Ruthi Frishtick, Ina Volis, et al.
Schizophrenia Research|November 26, 2011
Diminished language lateralization in schizophrenia corresponds to impaired inter-hemispheric functional connectivityMaya Bleich-Cohen, Haggai Sharon, Ronit Weizman, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 26, 2003
Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled studyMichael Poyurovsky, Danny Koren, Inna Gonopolsky, et al.
Pageof 4